Literature DB >> 6744557

Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.

M B Fowler, E L Alderman, S N Oesterle, G Derby, G T Daughters, E B Stinson, N B Ingels, R S Mitchell, D C Miller.   

Abstract

Left ventricular hemodynamics, dimensions and coronary sinus blood flows were measured simultaneously after infusions of dobutamine and dopamine. Ten patients were studied 6, 10 to 15, and 24 hr after cardiopulmonary bypass surgery. The dose of each drug was adjusted to increase cardiac output by 25%. Heart rate was held constant with atrial pacing. Dobutamine and dopamine increased peak left ventricular dP/dt from baseline values by 72% vs 58% during the early study, 77% vs 78% in the intermediate study, and 95% vs 79% in the late study (all NS, difference between drugs). Similarly, there were no significant differences in hemodynamic response or in cardiac dimensions after the two drugs in any period. Both drugs increased myocardial oxygen uptake during the intermediate and late studies (32% vs 33% and 34% vs 25%). With dobutamine this increase was matched by a similar increase in coronary blood flow; however, failure of the expected increase in coronary blood flow with dopamine suggested coronary constriction. Although dobutamine and dopamine have similar hemodynamic effects, dobutamine has the advantage of not limiting the increase in coronary blood flow associated with increased oxygen demand.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744557

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Current therapy of acute heart failure.

Authors:  Gerd F Rettig; Ludwig Bette
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 2.  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.

Authors:  Alexandre Mebazaa; Antonis A Pitsis; Alain Rudiger; Wolfgang Toller; Dan Longrois; Sven-Erik Ricksten; Ilona Bobek; Stefan De Hert; Georg Wieselthaler; Uwe Schirmer; Ludwig K von Segesser; Michael Sander; Don Poldermans; Marco Ranucci; Peter C J Karpati; Patrick Wouters; Manfred Seeberger; Edith R Schmid; Walter Weder; Ferenc Follath
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

Review 3.  Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.

Authors:  I Crozier; H Ikram
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

4.  Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.

Authors:  Ritesh Maharaj; Victoria Metaxa
Journal:  Crit Care       Date:  2011-06-08       Impact factor: 9.097

Review 5.  The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature.

Authors:  Peter P Roeleveld; J C A de Klerk
Journal:  World J Pediatr Congenit Heart Surg       Date:  2017-11-01

Review 6.  Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice.

Authors:  Vasiliki Bistola; Angelos Arfaras-Melainis; Eftihia Polyzogopoulou; Ignatios Ikonomidis; John Parissis
Journal:  Card Fail Rev       Date:  2019-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.